£148.87

Birkhauser Atypical Antipsychotics (Milestones in Drug Therapy)

Price data last checked 29 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£149 today · all-time low £149 (Apr 2026) · usually £149

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days • 62 data points (No recent data available)

Historical
Generating forecast...
£149.64 £148.69 £148.90 £149.11 £149.31 £149.52 £149.73 05 April 2026 20 April 2026 05 May 2026 20 May 2026 05 June 2026

Price Distribution

Price distribution over 62 days • 2 price levels

Days at Price
Current Price
47 days · current 15 days 0 12 24 35 47 £149 £150 Days at Price

Price Analysis

Most common price: £149 (47 days, 75.8%)

Price range: £149 - £150

Price levels: 2 different prices over 62 days

Description

The introduction of chlorpromazine in 1953, and haloperidol in 1958, into clinical practice dramatically altered the therapy of schizophrenic patients. Although representing by no means a cure for this severe psychiatric ill ness, it allowed, for the first time, to adequately control the severe hallu cinations and delusional beliefs which prevent these patients from leading a more or less independent life. Indeed these antipsychotics (and the many congeners that were to follow) significantly reduced the number ofchronic schizophrenic inpatients in psychiatric clinics all over the world. However soon after their introduction it became clear that, like all other available drugs, antipsychotics were by no means miracle drugs. In fact, two major problems appeared. First, the antipsychotics had very little effect on the so-called negative or defect symptoms, like social isolation, apathy and anhedonia, and secondly virtually all antipsychotics produced a number of side-effects, of which the neurological (often called extra pyramidal) side-effects were the most troublesome. Especially the tardive dyskinesia, which occurred in about 15 to 20% of the patients after pro longed treatment, represented a major problem in the treatment of schizo phrenic patients.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Psychotropic Agents: Part I: Antipsychotics and Antidepressants: 55 / 1 (Handbook of Experimental Pharmacology, 55 / 1)
78% match

Psychotropic Agents: Part I: Antipsychotics and Antidepressants: 55 / 1 (Handbook of Experimental Pharmacology, 55 / 1)

Springer

£109.14 30 Jun 2026
Methodology of the Evaluation of Psychotropic Drugs: 8 (Psychopharmacology Series, 8)
76% match

Methodology of the Evaluation of Psychotropic Drugs: 8 (Psychopharmacology Series, 8)

Springer

£77.88 03 Jul 2026
Anxiolytics (Milestones in Drug Therapy)
76% match

Anxiolytics (Milestones in Drug Therapy)

Birkhauser

£77.84 01 Jun 2026
Clinical Manual for Treatment of Schizophrenia
76% match

Clinical Manual for Treatment of Schizophrenia

American Psychiatric Association Publishing

£31.90 31 May 2026
Psychopharmaka bei psychiatrischen Erkrankungen: Neuroleptika, Tranquilizer, Antidepressiva. Anwendungsgrundsätze, Nebenwirkungen, Kontraindikationen, spezielle Hinweise und tabellarische Übersicht
75% match

Psychopharmaka bei psychiatrischen Erkrankungen: Neuroleptika, Tranquilizer, Antidepressiva. Anwendungsgrundsätze, Nebenwirkungen, Kontraindikationen, spezielle Hinweise und tabellarische Übersicht

Vieweg+Teubner Verlag

£57.06 29 May 2026
Treatment-Resistant Schizophrenia: Evidence-based Pharmacotherapy, Cognitive Behavioral Psychotherapy and Rehabilitation
74% match

Treatment-Resistant Schizophrenia: Evidence-based Pharmacotherapy, Cognitive Behavioral Psychotherapy and Rehabilitation

Springer

£54.67 16 May 2026
Clinical Manual of Geriatric Psychopharmacology
74% match

Clinical Manual of Geriatric Psychopharmacology

American Psychiatric Association Publishing

£55.39 28 May 2026
Lithium: Its Role in Psychiatric Research and Treatment
74% match

Lithium: Its Role in Psychiatric Research and Treatment

Springer

£77.74 04 Jun 2026
The Neuropsychology Of Schizophrenia (Brain, Behaviour and Cognition)
73% match

The Neuropsychology Of Schizophrenia (Brain, Behaviour and Cognition)

Psychology Press

£50.34 13 Jun 2026
Handbook of Neurochemistry and Molecular Neurobiology: Schizophrenia (Springer Reference)
73% match

Handbook of Neurochemistry and Molecular Neurobiology: Schizophrenia (Springer Reference)

Springer

£113.73 31 May 2026
The Medical Basis of Psychiatry
73% match

The Medical Basis of Psychiatry

Humana

£148.04 30 May 2026
Animal Models of Schizophrenia and Related Disorders: 59 (Neuromethods, 59)
73% match

Animal Models of Schizophrenia and Related Disorders: 59 (Neuromethods, 59)

Humana

£95.70 01 Jun 2026
Anxiety Disorders: Pathophysiology and Pharmacological Treatment
73% match

Anxiety Disorders: Pathophysiology and Pharmacological Treatment

Birkhauser

£77.89 26 May 2026
The Clinical Use of Antipsychotic Plasma Levels: Stahl's Handbooks (Stahl's Essential Psychopharmacology Handbooks)
73% match

The Clinical Use of Antipsychotic Plasma Levels: Stahl's Handbooks (Stahl's Essential Psychopharmacology Handbooks)

Cambridge University Press

£41.64 20 May 2026
Schizophrenia: Breaking Down the Barriers
73% match

Schizophrenia: Breaking Down the Barriers

Wiley-Blackwell

£90.00 04 Jun 2026
Affective and Schizoaffective Disorders: Similarities and Differences
72% match

Affective and Schizoaffective Disorders: Similarities and Differences

Springer

£80.23 02 Jul 2026
Neurological and Psychiatric Disorders (Current Clinical Neurology)
72% match

Neurological and Psychiatric Disorders (Current Clinical Neurology)

Humana

£103.24 01 Jun 2026
Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)
72% match

Psychopharmacology of the Developmental Disabilities (Disorders of Human Learning, Behavior, and Communication)

Springer

£76.38 01 Jun 2026
Psychotropic Agents: Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs: 55 / 3 (Handbook of Experimental Pharmacology, 55 / 3)
72% match

Psychotropic Agents: Part III: Alcohol and Psychotomimetics, Psychotropic Effects of Central Acting Drugs: 55 / 3 (Handbook of Experimental Pharmacology, 55 / 3)

Springer

£113.76 31 May 2026
Schizophrenia: Concepts and Clinical Management
72% match

Schizophrenia: Concepts and Clinical Management

Cambridge University Press

£34.58 05 Jun 2026
Behavioral Neurobiology of Schizophrenia and Its Treatment: 4 (Current Topics in Behavioral Neurosciences, 4)
72% match

Behavioral Neurobiology of Schizophrenia and Its Treatment: 4 (Current Topics in Behavioral Neurosciences, 4)

Springer

£148.05 31 May 2026
Reconstructing Schizophrenia
72% match

Reconstructing Schizophrenia

Routledge

£39.89 06 Jun 2026
School Psychopharmacology: Translating Research into Practice (Pediatric School Psychology)
72% match

School Psychopharmacology: Translating Research into Practice (Pediatric School Psychology)

Springer

£67.85 03 Jun 2026
Schizophrenia and Psychotic Spectrum Disorders (Primer On)
72% match

Schizophrenia and Psychotic Spectrum Disorders (Primer On)

Oxford University Press

£73.71 24 May 2026